- XBiotech Inc XBIT shares tumbled 38.9 percent to $10.40 after the company disclosed that the EMA rendered negative trend vote related to MAA for its candidate antibody for the treatment of colorectal cancer.
- Adamis Pharmaceuticals Corp ADMP shares declined 16.5 percent to $3.67. Adamis Pharmaceuticals priced its 4.28 million offering at $3.50 per share.
- Aevi Genomic Medicine, Inc GNMX shares dropped 15.1 percent to $1.58. Aevi Genomic Medicine presents updated results from its SAGA trial of AEVI-001 at the 6th World Congress on ADHD on April 21, 2017.
- bebe stores, inc. BEBE declined 14.4 percent to $3.22 as the company disclosed that it has entered into consulting agreement to sell all merchandise and inventory, and also close all its stores.
- Apricus Biosciences Inc APRI dropped 13 percent to $1.21. Apricus Biosciences priced its offering of 5.03 million units at $1.40 per unit.
- Onconova Therapeutics Inc ONTX shares fell 11.7 percent to $2.19. Onconova Therapeutics priced its 2.47 million share offering at $2.10 per share.
- Clearwater Paper Corp CLW shares dipped 11.4 percent to $50.50 after the company reported Q1 results. Clearwater Paper reported Q1 adjusted earnings of $0.64 per share on revenue of $437.5 million.
- Mattel, Inc. MAT declined 10.4 percent to $22.59 as the company reported weaker-than-expected results for its first quarter on Thursday.
- Electronics For Imaging, Inc. EFII fell 9.5 percent to $46.04 after the company reported downbeat quarterly revenue.
- Fairmount Santrol Holdings Inc FMSA shares dropped 9 percent to $5.05. Barclays downgraded Fairmount Santrol from Overweight to Equal-Weight.
- Cleveland BioLabs, Inc. CBLI shares dropped 7.7 percent to $3.94 after falling 16.27 percent on Thursday.
- National Beverage Corp. FIZZ shares declined 5.8 percent to $85.00. Credit Suisse downgraded National Beverage from Outperform to Neutral.
- Manhattan Associates, Inc. MANH shares slipped 5.4 percent to $47.87. Manhattan Associates posted upbeat quarterly earnings, but sales missed estimates. The company also cut its FY17 sales outlook.
- Maxim Integrated Products Inc. MXIM declined 3.6 percent to $43.83. Maxim Integrated reported Q3 earnings of $0.56 per share on revenue of $581 million. Evercore ISI Group downgraded the stock from Outperform to In-Line.
- Immune Pharmaceuticals Inc IMNP fell 3.3 percent to $3.53 after surging 49.59 percent on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
